.-Injection of a relatively large concentration of Shigella soluble antigen (SSA) into newborn mice results in specific immunological tolerance (paralysis) characterized by inability of the animals to form normal levels of anti-Shigella agglutinins upon subsequent challenge immunization with Shigella. Spleen and lymph nodes from Shigella-tolerant mice, as well as from normal and control immunized mice, were examined by the indirect immunofluorescence technique for evidence of cells containing anti-Shigella antibody. It was found that mice sacrificed at periodic intervals after neonatal administration of the tolerance-inducing inoculum of antigen and prior to and following challenge injection with a potential immunizing dose of SSA had only occasional specific fluorescing cells in spleens and lymph nodes. Tolerant mice also failed to develop significant levels of specific serum agglutinins after SSA challenge injection. In contrast, normal adult mice had a rapid appearance of numerous specific fluorescing cells in their spleens and lymph nodes, as well as a marked agglutinin response, after SSA immunization. Shigella-tolerant and normal control mice responded equally well with anti-Salmonella agglutinin formation and specific antibody-containing lymphoid cells after immunization with Salmonella antigen.
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Acquired immunological tolerance (paralysis) to either living or nonliving antigens may be induced in embryonic, neonatal, or adult animals (18, 25) . However, unless antigen is administered repeatedly, tolerance to nonliving antigens such as serum proteins, erythrocytes, or microbial products is generally only of relatively short duration (18, 25) . Thus, tolerance is thought by some investigators to be closely related to antigen persistence. However, "masking" of antibody production by persisting excess antigen is not considered to be a major factor in tolerance.
Some evidence for central failure of specific antibody formation in tolerant animals has been obtained through the use of cell-transfer procedures. Lymphoid tissue from tolerant animals cannot transfer specific antibody formation to normal or irradiated recipients (1, 2, 6, 10, 15, (21) (22) (23) 26) , as occurs after transfer of similar tissue from nontolerant immune donors. Transfer of syngeneic lymphoid cells or serum from immune donors to tolerant recipients usually results in only a transient immune response, apparently lasting only as long as the transferred cells or antibody. If antigen retention is essential for maintenance of tolerance, it appears that such retained antigen is sequestered intracellularly and is unavailable for extracellular neutralization by antibody, either actively produced by transferred donor cells or passively administered with immune serum.
Most studies on tolerance have been performed with serum protein antigens or with mammalian tissue (18, 25) . There have been only a few systematic studies concerned with induction and maintenance of tolerance to microbial antigens. Immunological "paralysis" in adult and newborn mice to pneumococcal polysaccharide (8, 9, 24) and tolerance of mice to LCM virus (27, 28, 19) have been the two classic examples of induced specific immunological unresponsiveness toward microorganisms.
In previous studies, acquired tolerance to Shigella paradysenteriae antigens was established in neonatal mice by a single large inoculum of Shigella antigen (17) . Transfer of lymphoid cells from Shigella-tolerant mice to normal recipients did not result in detectable agglutiin formation (10, 14, 15) , suggesting that immunogenic quantities of Shigella antigen were not transferred with the cell suspensions. However, nucleoprotein-rich subcellular fractions prepared from spleens of Shigella-tolerant mice were capable of stimulating anti-Shigella agglutinin formation in nonimmune recipients (11, 12 Induction oftolerance. Litters of newborn mice were injected with a single intraperitoneal (ip) inoculation of SSA (20 ,g of N) as described elsewhere (10, (14) (15) (16) (17) . Control animals from each litter were injected with saline.
Challenge immunization. Normal control and experimental animals were challenged at various ages with a single ip injection of SSA (10, 17) . In control experiments, a somatic antigen extract prepared by trypsin digestion of alcohol-killed suspensions of Salmonella typhosa was used for challenge immunization of normal and Shigella-tolerant mice (20 ,ug of N per mouse).
Agglutinin titration. Serum samples were obtained from individual mice by retro-orbital puncture prior to and at close periodic intervals after antigen injection. Agglutinins were determined by standard twofold serial dilution tube tests with 0.5-ml quantities of serum dilutions (1:10 through 1:10,240) and 0.2-ml volumes of an 0.05% suspension of alcohol-killed Shigella organisms.
Immunofluorescence staining. The indirect fluorescent-antibody staining procedure was used essentially as described by Coons (4, 5) . Individual spleen and lymph nodes obtained at autopsy immediately after sacrifice of experimental mice by cervical dislocation were rapidly frozen with Dry Ice. The organs were stored at -60 C until used. Sections 4 to 6 m,u thick were prepared with a cryostat immediately before staining. Antibody-containing cells were sought by first exposing the tissue sections to 0.2 ml of SSA, containing 0.5 ,ug of N, for 30 min at 37 C; sections were then gently rinsed twice with phosphate-buffered saline (pH 7.2), followed by an overlay with nonlabeled rabbit hyperimmune anti-Shigella serum diluted 1:50 or greater with sterile buffered saline (pH 7.2). (The anti-Shigella serum was pooled from rabbits immunized for a period of 12 months or longer with SSA emulsified in Freund's adjuvant (0.5 mg of SSA per ml per injection). Each serum had a specific agglutinin titer of 1:10,240 or greater). The antiserumtreated slides were incubated for 30 min at 37 C, followed by two further rinses with buffer and a final overlay with fluorescein isothiocyanate-labeled goat anti-rabbit -globulin diluted 1:50. For control slides, tissue sections were treated with the unrelated Salmonella antigen. There was a several-fold variation in the number of antibody-containing cells per square millimeter from section to section in spleens and lymph nodes (Table 2 ). At least 6 sections were counted per organ to obtain average counts. However, the change in counts after specific immunization was well above the random variation observed prior to immunization.
The number of fluorescing cells per square millimeter in spleen or lymph node sections correlated well with the serum agglutinin titer of each animal (Fig. 1, Tables 3-6 ). Increase in the number of fluorescing cells per tissue section of normal mice after immunization with SSA paralleled the increase in agglutinin titer ( SSA or saline did not have significant amounts of specific fluorescent staining indicative of antibody-containing cells. Table 3 indicates the lack of both serum agglutinins and fluorescing cells in spleens of neonatally injected mice tested 1 to 110 days after birth.
Effect of challenge injection. There was no significant increase in the amount of specific fluorescence observed within spleen or lymph node sections obtained 10 days after challenge of 6-to 8-week-old mice treated at birth with a tolerance-inducing inoculum of antigen ( Table  4 ). The absence of specific fluorescing lymphoid cells in challenged tolerant mice was similar to the lack of fluorescing cells in spleens and lymph nodes of unchallenged tolerant or normal mice. In contrast, control mice receiving saline at birth and then challenged with SSA at 6 to 8 weeks of age had relatively numerous fluorescing cells in their spleens and lymph nodes 10 days after challenge (Table 4) titers to Shigella were within expected normal limits in control mice and were markedly suppressed in tolerant mice (Table 4 ). There was no significant increase in the number of fluorescing cells in lymph nodes or spleens of Shigellatolerant mice sacrificed at varying time intervals after challenge injection with SSA at 8 weeks of age (Table 5 ). This contrasted sharply to the marked increase with time of both agglutinin titers and number of fluorescing cells in spleen and lymph nodes of normal mice examined at the same time intervals after challenge (Table 5) . Antibody response to heterologous antigen. Shigella-tolerant and normal control mice receiving a challenge immunization at 6 to 8 weeks of age with Salmonella antigen had numerous specific fluorescing cells in spleen and lymph node sections after treatment with Salmonella extract injected ip with SSA. and anti-Salmonella serum (Table 6 ). In addition, most sera from either Shigella-tolerant or control mice had anti-Salmonella titers ranging from 1:200 to 1:400 after challenge immunization with Salmonella antigen.
Comparison of agglutinin titers with number of fluorescing cells. The level of serum agglutinins to Shigella correlated well with the average number of specific antibody-containing cells detectable by immunofluorescence (Fig. 1) . Most normal adult mice had relatively high agglutinin titers and numerous fluorescing cells 7 to 10 days after an immunizing injection with Shigella, whereas most mice receiving a tolerance-inducing injection of antigen at birth had either low or undetectable titers and only rare fluorescing cells after challenge injection at 6 to 8 weeks of life. Serum titers and fluorescing cells were low or absent in both The results presented here confirm and extend those previously reported from this laboratory relative to the absence of specific antibodyforming cells in spleens of young mice tolerant to Shigella antigens. These results are also similar to those obtained by others with cell transfer procedures, indicating an apparent lack of antibody-containing cells in spleen and lymph nodes of mice tolerant to serum protein antigens (6, 23, 25) or to bacterial polysaccharides (2) .
Spleen cells from Shigella-tolerant mice cannot transfer agglutinin formation to normal or X-irradiated nonimmune recipients (10, 14, 15) 
